Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Nau Jeffrey Create: Alert

All | News | Filings
Date FiledTypeDescription
01/04/2023 4 Nau Jeffrey (President and CEO) has filed a Form 4 on Oyster Point Pharma, Inc.
Txns: Paid exercise price by delivering 2,607 shares @ $11.7, valued at $30.5k
Unknown transaction of 100,738 shares @ $0
Disposed/sold 47,975 shares @ $0
Disposed/sold 1,000 shares @ $0
Disposed/sold 350,000 rights @ $0
Disposed/sold 11,031 options to buy @ $0.2, valued at $2.2k
Disposed/sold 434,774 options to buy @ $1.02, valued at $443.5k
Disposed/sold 387,151 options to buy @ $5.33, valued at $2.1M
Disposed/sold 211,533 options to buy @ $32.65, valued at $6.9M
Disposed/sold 116,539 options to buy @ $18.77, valued at $2.2M
Disposed/sold 210,000 options to buy @ $16, valued at $3.4M
12/06/2022 4/A Nau Jeffrey (President and CEO) has filed a Form 4 on Oyster Point Pharma, Inc.
Txns: Paid exercise price by delivering 8,938 shares @ $11.2, valued at $100.1k
12/05/2022 4 Nau Jeffrey (President and CEO) has filed a Form 4 on Oyster Point Pharma, Inc.
Txns: Paid exercise price by delivering 6,217 shares @ $11.2, valued at $69.6k
07/08/2022 4 Nau Jeffrey (President and CEO) has filed a Form 4 on Oyster Point Pharma, Inc.
Txns: Granted 350,000 rights @ $0
01/11/2022 4 Nau Jeffrey (President and CEO) has filed a Form 4 on Oyster Point Pharma, Inc.
Txns: Granted 46,700 shares @ $0
Granted 210,000 options to buy @ $16, valued at $3.4M
10/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/30/2020 4 Nau Jeffrey (President and CEO) has filed a Form 4 on Oyster Point Pharma, Inc.
Txns: Exercised 5,000 options to buy @ $1.02, valued at $5.1k
02/05/2020 4 Nau Jeffrey (President and CEO) has filed a Form 4 on Oyster Point Pharma, Inc.
Txns: Granted 211,533 options to buy @ $32.65, valued at $6.9M
11/05/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/30/2019 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy